x
Filter:
Filters applied
- Statistics in Oncology Series
- Adjei, Alex ARemove Adjei, Alex A filter
- Ou, Fang-ShuRemove Ou, Fang-Shu filter
Publication Date
Please choose a date range between 2020 and 2021.
Statistics in Oncology Series
2 Results
- Statistics in Oncology SeriesOpen Access
Biomarker Discovery and Validation: Statistical Considerations
Journal of Thoracic OncologyVol. 16Issue 4p537–545Published online: February 1, 2021- Fang-Shu Ou
- Stefan Michiels
- Yu Shyr
- Alex A. Adjei
- Ann L. Oberg
Cited in Scopus: 21Biomarkers have various applications including disease detection, diagnosis, prognosis, prediction of response to intervention, and disease monitoring. In this era of precision medicine, having validated biomarkers to inform clinical decision making is more important than ever. In this article, we discuss best the practices and potential issues in biomarker discovery and validation. We encourage team science partnerships to bring cutting-edge discovery from bench to bedside, leading to improved patient care and outcomes. - Special Article: Statistics in Oncology SeriesOpen Archive
Guidelines for Statistical Reporting in Medical Journals
Journal of Thoracic OncologyVol. 15Issue 11p1722–1726Published online: August 25, 2020- Fang-Shu Ou
- Jennifer G. Le-Rademacher
- Karla V. Ballman
- Alex A. Adjei
- Sumithra J. Mandrekar
Cited in Scopus: 4Statistical methods are essential in medical research. They are used for data analysis and drawing appropriate conclusions. Clarity and accuracy of statistical reporting in medical journals can enhance readers’ understanding of the research conducted and the results obtained. In this manuscript, we provide guidelines for statistical reporting in medical journals for authors to consider, with a focus on the Journal of Thoracic Oncology.